MX9801664A - Formas zwitterionicas de trovafloxacina, procedimiento para su preparacion, composiciones que las contienen y uso de las mismas. - Google Patents

Formas zwitterionicas de trovafloxacina, procedimiento para su preparacion, composiciones que las contienen y uso de las mismas.

Info

Publication number
MX9801664A
MX9801664A MX9801664A MX9801664A MX9801664A MX 9801664 A MX9801664 A MX 9801664A MX 9801664 A MX9801664 A MX 9801664A MX 9801664 A MX9801664 A MX 9801664A MX 9801664 A MX9801664 A MX 9801664A
Authority
MX
Mexico
Prior art keywords
trovafloxacin
zwitterionic forms
methods
hygroscopic
pentahydrate
Prior art date
Application number
MX9801664A
Other languages
English (en)
Other versions
MXPA98001664A (es
Inventor
Douglas John Meldrum Allen
David Bruning Joseph
Timothy Norris
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9801664A publication Critical patent/MX9801664A/es
Publication of MXPA98001664A publication Critical patent/MXPA98001664A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Physical Water Treatments (AREA)
  • Processing Of Solid Wastes (AREA)

Abstract

Una forma zwitterionica de trovafloxacina de formula (I): seleccionada de entre el grupo formado por sus polimorfos higroscopicos y pentahidrato cristalinos y los procedimientos para su preparacion; la invencion se refiere además a procedimientos de uso, y composiciones farmacéuticas que los comprenden, los compuestos de la invencion para el tratamiento de infecciones bacterianas en mamíferos.
MXPA/A/1998/001664A 1995-08-29 1998-02-27 Formas zwitterionicas de trovafloxacina, procedimiento para su preparacion, composiciones que las contienen y uso de las mismas MXPA98001664A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US297595P 1995-08-29 1995-08-29
US002975 1995-08-29
PCT/IB1996/000756 WO1997007800A1 (en) 1995-08-29 1996-07-29 Zwitterionic forms of trovafloxacin

Publications (2)

Publication Number Publication Date
MX9801664A true MX9801664A (es) 1998-08-30
MXPA98001664A MXPA98001664A (es) 1998-11-12

Family

ID=

Also Published As

Publication number Publication date
AU6367696A (en) 1997-03-19
JP3188476B2 (ja) 2001-07-16
SK23898A3 (en) 1999-05-07
KR19990044232A (ko) 1999-06-25
GT199600072A (es) 1998-02-14
TR199800339T1 (xx) 1998-06-22
RU2144921C1 (ru) 2000-01-27
ZA967282B (en) 1998-03-02
PE12598A1 (es) 1998-03-20
CN1190889A (zh) 1998-08-19
HRP960395B1 (en) 2001-12-31
MA23966A1 (fr) 1997-04-01
BR9609998A (pt) 1999-07-06
OA10669A (en) 2000-11-06
CZ56698A3 (cs) 1999-02-17
CA2229786A1 (en) 1997-03-06
CO4480739A1 (es) 1997-07-09
JPH10511692A (ja) 1998-11-10
DZ2087A1 (fr) 2002-07-22
HRP960395A2 (en) 1998-06-30
NO980862L (no) 1998-02-27
CA2229786C (en) 2002-02-19
AU704115B2 (en) 1999-04-15
IL122651A (en) 2000-02-17
HUP9900170A2 (hu) 1999-05-28
AP9600853A0 (en) 1996-10-31
MY113874A (en) 2002-06-29
TNSN96109A1 (fr) 2005-03-15
NO980862D0 (no) 1998-02-27
AP636A (en) 1998-04-09
HUP9900170A3 (en) 1999-11-29
EP0850060A1 (en) 1998-07-01
IL122651A0 (en) 1998-08-16
WO1997007800A1 (en) 1997-03-06
YU48396A (sh) 1998-12-23
NO309814B1 (no) 2001-04-02
NZ312199A (en) 1999-06-29
PL325170A1 (en) 1998-07-06
KR100343909B1 (ko) 2003-04-10
AR003985A1 (es) 1998-09-30

Similar Documents

Publication Publication Date Title
MY113733A (en) Salts of an anti-migraine indole derivative
UA70298A (uk) Похідні с-4"-заміщених макролідів, спосіб їх одержання, проміжні сполуки, фармацевтична композиція та спосіб лікування бактеріальної інфекції або протозойної інфекції
BG103292A (en) 6-0-substituted ketolides possessing antibacterial effect
EP0863755A4 (en) ANTITHROMBOTIC DIAMINES
LU91145I9 (es)
IL133623A0 (en) Antithrombotic agents
IL133627A0 (en) Antithrombotic agents
MX9605741A (es) Clorhidrato cristalino del (r)-(-)-2-{n-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzisotiazol-2-il)-butil ]-aminometil} cromano.
AP9801253A0 (en) 9-Oxime erythromycin derivatives.
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
BG104640A (en) Novel erythromycin derivatives
AP2001002131A0 (en) Novel macrolide antibiotics.
MY122353A (en) 13-membered azalides and their use as antibiotic agents
MX9804046A (es) 6-0-metil eritromicina d y proceso para hacerla.
CA2280328A1 (en) C11 carbamates of macrolide antibacterials
DK1057828T3 (da) Orale trovafloxacin-suspensioner
EP1019047A4 (en) ANTITHROMBOTIC AGENTS
CA2229786A1 (en) Zwitterionic forms of trovafloxacin
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
AP9801235A0 (en) Erythromycin derivatives.
AP2002002494A0 (en) Hygromycin derivatives.
MY118946A (en) Novel intermediates and their use to prepare n, n''- bridged bisindolylmaleimides
UA48982C2 (uk) Поліморфи проліків тровафлоксацину, спосіб їх отримання, спосіб лікування бактеріальної інфекції і фармацевтична композиція
DE69824410D1 (en) Antithrombosemittel
AU1434201A (en) Antithrombotic agents

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees